Genetic deficiency of adiponectin protects against acute kidney injury

Slides:



Advertisements
Similar presentations
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Advertisements

Inflammatory cytokines in acute renal failure
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 84, Issue 1, Pages (July 2013)
Volume 78, Issue 11, Pages (December 2010)
Volume 85, Issue 3, Pages (March 2014)
Progranulin protects against renal ischemia/reperfusion injury in mice
Volume 91, Issue 2, Pages (February 2017)
Dong Zhou, Yingjian Li, Lin Lin, Lili Zhou, Peter Igarashi, Youhua Liu 
Volume 88, Issue 3, Pages (September 2015)
Volume 79, Issue 2, Pages (January 2011)
G.-T. Shin, D.R. Kim, J.-E. Lim, H. Yim, H. Kim  Kidney International 
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 86, Issue 1, Pages (July 2014)
Jianlin Chen, Martin M. Matzuk, Xin J. Zhou, Christopher Y. Lu 
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
The Case ∣ Acute renal failure and anemia
Jinu Kim, Kelly E. Long, Kang Tang, Babu J. Padanilam 
Volume 82, Issue 8, Pages (October 2012)
Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury.
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 79, Issue 6, Pages (March 2011)
Volume 75, Issue 3, Pages (February 2009)
Volume 88, Issue 3, Pages (September 2015)
Volume 84, Issue 5, Pages (November 2013)
Volume 82, Issue 10, Pages (November 2012)
Genistein protects the kidney from cisplatin-induced injury
Volume 75, Issue 2, Pages (January 2009)
Volume 73, Issue 5, Pages (March 2008)
Volume 87, Issue 1, Pages (January 2015)
Volume 86, Issue 3, Pages (September 2014)
Volume 73, Issue 4, Pages (February 2008)
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury  Dong Zhou, Roderick.
Volume 82, Issue 9, Pages (November 2012)
Volume 85, Issue 4, Pages (April 2014)
Autophagy in proximal tubules protects against acute kidney injury
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Volume 81, Issue 3, Pages (February 2012)
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 79, Issue 1, Pages (January 2011)
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Volume 75, Issue 8, Pages (April 2009)
Volume 80, Issue 12, Pages (December 2011)
Volume 82, Issue 4, Pages (August 2012)
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 66, Issue 6, Pages (December 2004)
Volume 83, Issue 3, Pages (March 2013)
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 85, Issue 1, Pages (January 2014)
Volume 79, Issue 4, Pages (February 2011)
Volume 65, Issue 5, Pages (May 2004)
Volume 68, Issue 2, Pages (August 2005)
Volume 85, Issue 4, Pages (April 2014)
Volume 76, Issue 7, Pages (October 2009)
Volume 75, Issue 5, Pages (March 2009)
Volume 83, Issue 6, Pages (June 2013)
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 79, Issue 2, Pages (January 2011)
Volume 74, Issue 1, Pages (July 2008)
Volume 85, Issue 1, Pages (January 2014)
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 67, Issue 4, Pages (April 2005)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 76, Issue 8, Pages (October 2009)
Volume 95, Issue 5, Pages (May 2019)
Volume 85, Issue 1, Pages (January 2014)
Fig. 3. Neutrophil infiltration persisted in Bax KOBM → WT chimera throughout the recovery phase of IRI and was associated with delayed functional, histological.
Volume 75, Issue 8, Pages (April 2009)
Presentation transcript:

Genetic deficiency of adiponectin protects against acute kidney injury Xiaogao Jin, Jiyuan Chen, Zhaoyong Hu, Lawrence Chan, Yanlin Wang  Kidney International  Volume 83, Issue 4, Pages 604-614 (April 2013) DOI: 10.1038/ki.2012.408 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Adiponectin is upregulated in the kidney after ischemia–reperfusion injury. (a) Adiponectin (APN) messenger RNA (mRNA) is induced significantly in kidneys of wild-type (WT) mice after ischemia–reperfusion injury (IRI) compared with sham-operated mice. **P<0.01 vs. WT sham. n=4 in each group. (b) Representative photomicrographs of kidney sections stained for adiponectin (brown) and counterstained with hematoxylin (blue) (original magnification × 400). (c) Representative western blot under nonreducing conditions shows that all isoforms of adiponectin protein is induced in IRI kidneys of WT mice. (d) Quantification of serum adiponectin levels in sham-operated mice and mice with IRI. **P<0.01 vs. WT sham. n=5–6 in each group. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HMW, high-molecular-weight; KO, knockout. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Genetic deficiency of adiponectin protects kidney against ischemia–reperfusion injury (IRI). (a) Effect of adiponectin deficiency on serum creatinine in wild-type (WT) and adiponectin-knockout (APN-KO) mice after sham or IRI. **P<0.01 vs. WT sham, ##P<0.05 vs. WT IRI; ++P<0.05 vs. APN-KO IRI. n=5 in each group. (b) Effect of adiponectin deficiency on serum urea nitrogen in WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham, ##P<0.05 vs. WT IRI; ++P<0.05 vs. APN-KO IRI. n=5 in each group. (c) Representative photomicrographs of hematoxylin and eosin staining for kidney sections of WT and APN-KO mice after sham or IRI. (d) Quantitative histological assessment of tubular damage after IRI in WT and APN-KO mice. **P<0.05 vs. WT IRI. n=5–6 in each group. BUN, blood urea nitrogen. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Adiponectin deficiency protects tubular epithelial cells from apoptosis in ischemia–reperfusion injury (IRI) kidney. (a) Representative photomicrographs of kidney sections stained for apoptotic cells (brown) and counterstained with methyl green (green) in kidneys of wild-type (WT) and adiponectin-knockout (APN-KO) mice after sham or IRI. (Original magnification × 400.) (b) Quantitative analysis of apoptotic cells in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI; +P<0.05 vs. APN-KO IRI. n=5–6 in each group. HPF, high power field; TUNEL, terminal transferase dUTP nick-end labeling. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Adiponectin deficiency inhibits caspase 3 activation in tubular epithelial cells. (a) Representative photomicrographs of kidney sections stained for cleaved caspase 3 (brown) and counterstained with hematoxylin (blue) in wild-type (WT) and adiponectin-knockout (APN-KO) mice after sham or ischemia–reperfusion injury (IRI). (Original magnification × 400.) (b) Quantitative analysis of cleaved caspase 3 expression in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT controls; ##P<0.01 vs. WT IRI, ++P<0.01 vs. APN-KO IRI. n=5–6 in each group. (c) Representative western blots show cleaved caspase 3 protein expression in kidneys of WT and APN-KO mice after sham or IRI. (d) Quantitative analysis of cleaved caspase 3 protein expression in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI, ++P<0.01 vs. APN-KO IRI. n=5–6 in each group. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Adiponectin deficiency reduces Bax protein expression and p53 activation in tubular epithelial cells. (a) Representative photomicrographs of kidney sections stained for Bax (brown) and counterstained with hematoxylin (blue) in wild-type (WT) and adiponectin-knockout (APN-KO) mice after sham or ischemia–reperfusion injury (IRI). (b) Quantitative analysis of Bax protein expression density in the kidney of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT controls; ##P<0.01 vs. WT IRI; ++P<0.01 vs. APN-KO IRI. n=5–6 in each group. (c) Representative photomicrographs of kidney sections stained for phospho-p53 (brown) and counterstained with hematoxylin (blue) in WT and APN-KO mice after sham or IRI. (Original magnification × 400.) (d) Quantitative analysis of phospho-p53 in the kidney of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI, ++P<0.01 vs. APN-KO IRI. n=5–6 in each group. HPF, high power field. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 6 Targeted disruption of adiponectin inhibits infiltration of neutrophils, macrophages, and T cells in the kidney after ischemia–reperfusion injury (IRI). (a) Representative photomicrographs of kidney sections stained for MPO (a neutrophils marker) (brown) and counterstained with hematoxylin (blue) in wild-type (WT) and adiponectin-knockout (APN-KO) mice after sham or IRI. (b) Quantitative analysis of MPO+ neutrophils in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI; ++P<0.01 vs. APN-KO IRI. n=5–6 in each group. (c) Representative photomicrographs of kidney sections stained for F4/80 (a macrophage marker) (brown) and counterstained with hematoxylin (blue) in WT and APN-KO mice after sham or IRI. (d) Quantitative analysis of F4/80+ macrophages in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI; +P<0.05 vs. APN-KO IRI. n=5–6 in each group. (e) Representative photomicrographs of kidney sections stained for CD3 (a T-lymphocyte marker) (brown) and counterstained with hematoxylin (blue) in WT and APN-KO mice after sham or IRI. (f) Quantitative analysis of CD3+ T cells in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI; ++P<0.01 vs. APN-KO IRI. n=5–6 in each group. HPF, high power field. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 7 Targeted disruption of adiponectin suppresses gene expression of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and MCP-1 in the kidney after ischemia–reperfusion injury (IRI). (a) Bar graph shows quantitative analysis of TNF-α messenger RNA (mRNA) expression in kidneys of wild-type (WT) and adiponectin-knockout (APN-KO) mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI; +P<0.05 vs. APN-KO IRI. n=4 in each group. (b) Bar graph shows quantitative analysis of IL-6 mRNA expression in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI; +P<0.05 vs. APN-KO IRI. n=4 in each group. (c) Bar graph shows quantitative analysis of MCP-1 mRNA expression in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI;+P<0.05 vs. APN-KO IRI. n=4 in each group. (d) Bar graph shows quantitative analysis of MIP-2 mRNA expression in kidneys of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI; +P<0.05 vs. APN-KO IRI. n=4 in each group. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 8 Targeted disruption of adiponectin inhibits NF-κB activation in the kidney during ischemia–reperfusion injury (IRI). (a) Representative photomicrographs of kidney sections stained for p65 (brown) and counterstained with hematoxylin (blue) in wild-type (WT) and adiponectin-knockout (APN-KO) mice after sham or IRI. (Original magnification × 400.) (b) Quantitative analysis of p65 in the kidney of WT and APN-KO mice after sham or IRI. **P<0.01 vs. WT sham; ##P<0.01 vs. WT IRI; ++P<0.01 vs. APN-KO IRI. n=5–6 in each group. HPF, high power field. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 9 Bone marrow cell–produced adiponectin mediates kidney injury. (a) Effect of adiponectin deficiency in bone marrow cells on serum urea nitrogen. **P<0.01 vs. wild-type (WT)→WT sham; ++P<0.01 vs. WT→WT ischemia–reperfusion injury (IRI); #P<0.05 vs. knockout (KO)→WT; &P>0.05 vs. WT→KO IRI. n=3–4 in each group. (b) Quantitative histological assessment of tubular damage. **P<0.05 vs. WT→WT IRI; ++P<0.01 vs. KO→WT IRI; &P>0.05 vs. WT→KO IRI. n=3–4 in each group. BUN, blood urea nitrogen. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 10 LY 294002 blocks adiponectin-induced migration of Raw 264.7 macrophages. **P<0.01 vs. vehicle controls; ##P<0.01 vs. adiponectin (APN)-treated group. n=3 in each group. HPF, high power field. Kidney International 2013 83, 604-614DOI: (10.1038/ki.2012.408) Copyright © 2013 International Society of Nephrology Terms and Conditions